Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GENPHARMASEC LTD.

NSE : NABSE : 531592ISIN CODE : INE861N01036Industry : Dyes & PigmentsHouse : Private

BSE1.420.04 (+2.9 %)

PREV CLOSE ( ) 1.38

OPEN PRICE ( ) 1.38

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 396412

TODAY'S LOW / HIGH ( )1.36 1.44

52 WK LOW / HIGH ( ) 1.364.32

NSE

This Company is not listed in NSE

Quarters

Select year

( in Million)

Particulars

Sep 2025

Jun 2025

Mar 2025

Dec 2024

Audited / UnAudited

UnAudited

Net Sales

326.37

120.43

140.1

84.84

Total Expenditure

331.1

111.04

150.09

77.48

PBIDT (Excl OI)

-4.73

9.39

-9.99

7.36

Other Income

4.65

6.95

9.37

8.12

Operating Profit

-0.08

16.34

-0.62

15.48

Interest

2.25

1.23

1.06

1.57

Exceptional Items

PBDT

-2.33

15.11

-1.69

13.91

Depreciation

5.62

2.66

2.56

0.99

Profit Before Tax

-7.95

12.45

-4.25

12.92

Tax

3.8

0.31

-1.55

5.12

Provisions and contingencies

Profit After Tax

-11.75

12.14

-2.7

7.79

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

-11.75

12.14

-2.7

7.79

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

-11.76

12.15

-2.71

7.8

Equity Capital

553.72

Face Value (IN RS)

Reserves

Calculated EPS

-0.02

0.02

-0.00

0.01

Calculated EPS (Annualised)

-0.08

0.08

-0.01

0.05

No of Public Share Holdings

387718700

% of Public Share Holdings

70.02

PBIDTM% (Excl OI)

-1.44

7.79

-7.13

8.67

PBIDTM%

-0.02

13.56

-0.44

18.24

PBDTM%

-0.71

12.54

-1.20

16.39

PBTM%

-2.43

10.33

-3.03

15.22

PATM%

-3.60

10.08

-1.92

9.19

Notes

Risk Disclosures on Derivatives

Quarterly Results

GENPHARMASEC LTD.